SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009282
Filing Date
2024-06-18
Accepted
2024-06-18 16:10:58
Documents
15
Period of Report
2024-06-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nxtc-20240618x8k.htm   iXBRL 8-K 49415
2 EX-10.1 nxtc-20240618xex10d1.htm EX-10.1 64166
  Complete submission text file 0001558370-24-009282.txt   261701

Data Files

Seq Description Document Type Size
3 EX-101.SCH nxtc-20240618.xsd EX-101.SCH 4060
4 EX-101.DEF nxtc-20240618_def.xml EX-101.DEF 2850
5 EX-101.LAB nxtc-20240618_lab.xml EX-101.LAB 17906
6 EX-101.PRE nxtc-20240618_pre.xml EX-101.PRE 11816
18 EXTRACTED XBRL INSTANCE DOCUMENT nxtc-20240618x8k_htm.xml XML 5032
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38905 | Film No.: 241051862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)